Reata Pharmaceuticals, Inc. Class A (RETA)

150.80
3.10 2.00
NASDAQ
Prev Close 153.92
Open 152.03
Day Low/High 148.56 / 153.90
52 Wk Low/High 70.00 / 257.96
Volume 33.19K
Exchange NASDAQ
Shares Outstanding 33.58B
Market Cap 5.02B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

I'm Seeing Quite a Bit of Good Action in Individual Stocks

I'm Seeing Quite a Bit of Good Action in Individual Stocks

The bulls are hoping that this dead cat bounce transitions into a V-shaped bounce.

Trade With Your Cup Half Full

Trade With Your Cup Half Full

I learned from Jim Cramer long ago to focus on what can go right if you want to ride the momentum of stocks.

2 Promising Biotech Stocks That Insiders Are Snapping Up

2 Promising Biotech Stocks That Insiders Are Snapping Up

Shares of Iovance Biotherapeutics and Reata Pharmaceuticals took it on the chin in the fourth quarter, but both companies seem ready to reward shareholders for their patience.

Here's a Handful of Small Biotechs Where Insiders Are Buying

Here's a Handful of Small Biotechs Where Insiders Are Buying

Quotient Limited, Iovance Biotherapeutics and AVEO Pharmaceuticals are among the names seeing insider purchases.

2 Key 'Rules' When Investing in Biotech Stocks

2 Key 'Rules' When Investing in Biotech Stocks

Remembering these 'rules of the road' is vital in this highly volatile space.

Biotech Stocks Getting Their Due Respect

Biotech Stocks Getting Their Due Respect

Here are two I think will bounce back before the end of the year.

How I Invest In Biotech Stocks

How I Invest In Biotech Stocks

Here's two 'rules of the road' when investing in this highly volatile space.

3 Good Bargain Stocks With Insider Buying

3 Good Bargain Stocks With Insider Buying

I continue to keep a 'shopping list' at the ready for the next dip in the market.

The January Effect Is on Time This Year

The January Effect Is on Time This Year

I continue to believe that biotech and biopharma stocks will outperform in 2018.

Seeing the Same Old Patterns Ahead of Fed News

Seeing the Same Old Patterns Ahead of Fed News

Buyers expect a dovish Fed and are still trying to put money to work.

Bounce Has Gone Bust Pretty Quickly

Bounce Has Gone Bust Pretty Quickly

If the market closes weak today, it will be marked with an exclamation point.